Technical Analysis for WINT - Windtree Therapeutic

Grade Last Price % Change Price Change
grade C 4.01 0.00% 0.0000
WINT closed unchanged on Friday, September 13, 2019, on 6 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Down Up
See historical WINT trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%

Older signals for WINT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Windtree Therapeutics, Inc., a biotechnology company, focuses on developing surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform includes a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and drug-delivery technologies being developed to enable the noninvasive administration of aerosolized KL4 surfactant. The company's lead development program comprises AEROSURF, a drug/device product that has completed Phase IIb clinical trial to treat respiratory distress syndrome in premature infants. It is also developing other aerosolized KL4 surfactant products. Windtree Therapeutics, Inc. has a strategic collaboration with Eleison Pharmaceuticals, Inc. for using its proprietary aerosol delivery system to deliver inhaled lipid cisplatin in combination with KL4 surfactant. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania.
Medicine Biotechnology Medical Specialties Branches Of Biology Respiratory Diseases Respiratory Physiology Drug Delivery Technologies Potential Applications Neonatology
Is WINT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.35
52 Week Low 2.05
Average Volume 1,708
200-Day Moving Average 3.8576
50-Day Moving Average 4.2062
20-Day Moving Average 3.891
10-Day Moving Average 3.796
Average True Range 0.4191
ADX 53.26
+DI 20.431
-DI 42.4903
Chandelier Exit (Long, 3 ATRs ) 2.8927
Chandelier Exit (Short, 3 ATRs ) 3.9073
Upper Bollinger Band 4.5377
Lower Bollinger Band 3.2443
Percent B (%b) 0.59
BandWidth 33.240812
MACD Line -0.1183
MACD Signal Line -0.144
MACD Histogram 0.0257
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.0100
Resistance 3 (R3) 4.0100 4.0100 4.0100
Resistance 2 (R2) 4.0100 4.0100 4.0100 4.0100
Resistance 1 (R1) 4.0100 4.0100 4.0100 4.0100 4.0100
Pivot Point 4.0100 4.0100 4.0100 4.0100 4.0100
Support 1 (S1) 4.0100 4.0100 4.0100 4.0100 4.0100
Support 2 (S2) 4.0100 4.0100 4.0100 4.0100
Support 3 (S3) 4.0100 4.0100 4.0100
Support 4 (S4) 4.0100